Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

761 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reevaluation of prognostic significance of symptoms in Hodgkin's disease.
Gobbi PG, Cavalli C, Gendarini A, Crema A, Ricevuti G, Federico M, Di Prisco U, Ascari E. Gobbi PG, et al. Among authors: federico m. Cancer. 1985 Dec 15;56(12):2874-80. doi: 10.1002/1097-0142(19851215)56:12<2874::aid-cncr2820561227>3.0.co;2-2. Cancer. 1985. PMID: 4052959 Free article.
Serum albumin in Hodgkin's disease.
Gobbi PG, Gendarini A, Crema A, Cavalli C, Attardo-Parrinello G, Federico M, Di Prisco U, Ascari E. Gobbi PG, et al. Among authors: federico m. Cancer. 1985 Jan 15;55(2):389-93. doi: 10.1002/1097-0142(19850115)55:2<389::aid-cncr2820550216>3.0.co;2-f. Cancer. 1985. PMID: 2578086 Free article.
Hodgkin's disease prognosis: a directly predictive equation.
Gobbi PG, Cavalli C, Federico M, Bertoloni D, Di Prisco UA, Rossi A, Silingardi V, Mauri C, Ascari E. Gobbi PG, et al. Among authors: federico m. Lancet. 1988 Mar 26;1(8587):675-9. doi: 10.1016/s0140-6736(88)91477-8. Lancet. 1988. PMID: 2895213
Tonsillectomy: a prognostic factor in Hodgkin's disease?
Gobbi PG, Cavalli P, Franzini B, Di Prisco U, Federico M, Bonacorsi G. Gobbi PG, et al. Among authors: federico m. Tumori. 1981 Oct 31;67(5):425-30. doi: 10.1177/030089168106700506. Tumori. 1981. PMID: 7324174
A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.
Baldini L, Guffanti A, Gobbi P, Colombi M, Federico M, Avanzini P, Cavanna L, Pieresca C, Silingardi V, Maiolo AT. Baldini L, et al. Among authors: federico m. Cancer. 1997 Mar 15;79(6):1234-40. doi: 10.1002/(sici)1097-0142(19970315)79:6<1234::aid-cncr24>3.0.co;2-#. Cancer. 1997. PMID: 9070503
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: the Gruppo Italiano per lo Studio dei Linfomi Experience.
Gobbi PG, Pieresca C, Frassoldati A, Carotenuto M, Di Renzo N, La Sala A, Berté R, Avanzini P, Federico M, Silingardi V, Ascari E. Gobbi PG, et al. Among authors: federico m. J Clin Oncol. 1996 Feb;14(2):527-33. doi: 10.1200/JCO.1996.14.2.527. J Clin Oncol. 1996. PMID: 8636767 Clinical Trial.
761 results